Prospekta for ADHD symptoms in children
About this title
Read the official source — NCT04569357Researchers compared Prospekta and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Understand this study
What did researchers investigate?
Researchers compared Prospekta and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Who was this study for?
This study was for people with ADHD. Listed age limits: 7 years to 12 years. Other eligibility criteria applied.
- Listed locations
- Bryansk and 30 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 363
- Sponsor
- Materia Medica Holding
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Russia
- Age range
- From 7 Years to 12 Years
- Official registry ID
- NCT04569357
- Official title
Show the full official title
Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Bryansk, Russia · Chelyabinsk, Russia · Engel's, Russia
17 more locations
- Kazan', Russia
- Krasnodar, Russia
- Moscow, Russia
- Nizhny Novgorod, Russia
- Orenburg, Russia
- Perm, Russia
- Rostov-on-Don, Russia
- Ryazan, Russia
- Saint Petersburg, Russia
- Saratov, Russia
- Smolensk, Russia
- Stavropol, Russia
- Tver', Russia
- Ulyanovsk, Russia
- Yaroslavl, Russia
- Yekaterinburg, Russia
- Russia
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Prospekta and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Who is behind this study?
The study sponsor is Materia Medica Holding.
Did this study involve medication?
Yes. The study involved medication, including Prospekta and Placebo.
Who was this study for?
This study was for people with ADHD. Listed age limits: 7 years to 12 years. Other eligibility criteria applied.
